Cited by 86Transplantation: Methods and OutcomesOrgan and Tissue Transplantation ResearchT-cell and B-cell Immunology

Interleukin (IL)-1 promotes allogeneic T cell intimal infiltration and IL-17 production in a model of human artery rejection

Open access
Rao, Deepak A., Eid, Raymond E., Qin, Lingfeng, Yi, Tai, Kirkiles-Smith, Nancy C., Tellides, George, Pober, Jordan S.·2008·The Journal of Experimental Medicine

Abstract

Interleukin (IL) 1α produced by human endothelial cells (ECs), in response to tumor necrosis factor (TNF) or to co-culture with allogeneic T cells in a TNF-dependent manner, can augment the release of cytokines from alloreactive memory T cells in vitro. In a human–mouse chimeric model of artery allograft rejection, ECs lining the transplanted human arteries express IL-1α, and blocking IL-1 reduces the extent of human T cell infiltration into the artery intima and selectively inhibits IL-17 production by infiltrating T cells. In human skin grafts implanted on immunodeficient mice, administration of IL-17 is sufficient to induce mild inflammation. In cultured cells, IL-17 acts preferentially on vascular smooth muscle cells rather than ECs to enhance production of proinflammatory mediators, including IL-6, CXCL8, and CCL20. Neutralization of IL-17 does not reduce T cell infiltration into allogeneic human artery grafts, but markedly reduces IL-6, CXCL8, and CCL20 expression and selectively inhibits CCR6+ T cell accumulation in rejecting arteries. We conclude that graft-derived IL-1 can promote T cell intimal recruitment and IL-17 production during human artery allograft rejection, and suggest that targeting IL-1 in the perioperative transplant period may modulate host alloreactivity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20081661

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • IL-1α release from injured endothelial cells promotes allogeneic T cell infiltration in a mouse-human chimeric model of artery allograft rejection.

    “In the case of IL-1α, its release from injured endothelial cells promotes allogeneic T cell infiltration in a mouse–human chimeric model of artery allograft rejection76.”

    From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [76]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [5]Choi, J., D.R. Enis, K.P. Koh, S.L. Shiao, and J.S. Pober. 2004. T lymphocyte-endothelial cell interactions. Annu. Rev. Immunol. 22: 683–709. 15032593
  2. [20]Chabaud, M., J.M. Durand, N. Buchs, F. Fossiez, G. Page, L. Frappart, and P. Miossec. 1999. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 42: 963–970. 10323452

Cited by

Sorted by citations

Authors
Rao, D. A., Eid, R. E., Qin, L., Yi, T., Kirkiles-Smith, N. C., Tellides, G., & Pober, J. S.
Affiliations
  • 1Department of Immunobiology
  • 2Department of Surgery
  • Yale University (US)
Venue
The Journal of Experimental Medicine
Published
2008-12-15
Volume
205
Issue
13
Pages
3145-3158
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2152079015
Cited by
86
References
60
Citations by year
2026: 2 · 2025: 3 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 4 · 2020: 7 · 2019: 1 · 2018: 1 · 2017: 4 · 2016: 9 · 2015: 7 · 2014: 8 · 2013: 5 · 2012: 11
FWCI
6.67
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • The Journal of Experimental Medicine (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
Funders
  • National Heart, Lung, and Blood Institute (P01HL070295, HL070295)
  • National Institute of General Medical Sciences (5T32 GM 07205, T32GM007205)
Topics
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
  • Health Sciences › Medicine › Transplantation › Organ and Tissue Transplantation Research
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
interleukin-1, IL-17, allograft rejection, T cell infiltration, intimal inflammation, endothelial cells, CCR6, vascular smooth muscle cells, interleukin-6, interleukin-8, CCL20, alloreactivity, skin grafts, transplantation immunology
MeSH terms
Animals, Arteries, Cells, Cultured, Graft Rejection, Humans, Inflammation, Lymphocyte Activation, Transplantation, Homologous, CD4-Positive T-Lymphocytes, Skin Transplantation, Cytokines, Mice, SCID, Tunica Intima, Chemokines, Interleukin-17, Oligonucleotide Array Sequence Analysis, Endothelial Cells, Mice, Interleukin-1alpha, Receptors, CCR6

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review